These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 32501655)

  • 21. Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis.
    Titcombe PJ; Wigerblad G; Sippl N; Zhang N; Shmagel AK; Sahlström P; Zhang Y; Barsness LO; Ghodke-Puranik Y; Baharpoor A; Hansson M; Israelsson L; Skriner K; Niewold TB; Klareskog L; Svensson CI; Amara K; Malmström V; Mueller DL
    Arthritis Rheumatol; 2018 Dec; 70(12):1933-1945. PubMed ID: 29927106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibody against citrullinated peptides obtained from rheumatoid arthritis patients reacts with numerous citrullinated microbial and food proteins.
    Tsuda R; Ozawa T; Kobayashi E; Hamana H; Taki H; Tobe K; Sugiyama E; Iwamoto M; Imura J; Kishi H; Muraguchi A
    Arthritis Rheumatol; 2015 May; 67(8):2020-31. PubMed ID: 25892475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope.
    Larid G; Pancarte M; Offer G; Clavel C; Martin M; Pradel V; Auger I; Lafforgue P; Roudier J; Serre G; Balandraud N
    Front Immunol; 2021; 12():692041. PubMed ID: 34248985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment.
    Sakkas LI; Bogdanos DP; Katsiari C; Platsoucas CD
    Autoimmun Rev; 2014 Nov; 13(11):1114-20. PubMed ID: 25182207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies From Single Circulating Plasmablasts React With Citrullinated Antigens and Porphyromonas gingivalis in Rheumatoid Arthritis.
    Li S; Yu Y; Yue Y; Liao H; Xie W; Thai J; Mikuls TR; Thiele GM; Duryee MJ; Sayles H; Payne JB; Klassen LW; O'Dell JR; Zhang Z; Su K
    Arthritis Rheumatol; 2016 Mar; 68(3):614-26. PubMed ID: 26474325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
    Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E
    Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
    van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
    Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens.
    Fernandes-Cerqueira C; Ossipova E; Gunasekera S; Hansson M; Mathsson L; Catrina AI; Sommarin Y; Klareskog L; Lundberg K; Rönnelid J; Göransson U; Jakobsson PJ
    Arthritis Res Ther; 2015 Jun; 17(1):155. PubMed ID: 26059223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural Basis of Cross-Reactivity of Anti-Citrullinated Protein Antibodies.
    Ge C; Xu B; Liang B; Lönnblom E; Lundström SL; Zubarev RA; Ayoglu B; Nilsson P; Skogh T; Kastbom A; Malmström V; Klareskog L; Toes REM; Rispens T; Dobritzsch D; Holmdahl R
    Arthritis Rheumatol; 2019 Feb; 71(2):210-221. PubMed ID: 30152126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
    Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
    Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.
    Goules JD; Goules AV; Tzioufas AG
    Clin Exp Immunol; 2013 Oct; 174(1):10-7. PubMed ID: 23711220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
    Shi J; Knevel R; Suwannalai P; van der Linden MP; Janssen GM; van Veelen PA; Levarht NE; van der Helm-van Mil AH; Cerami A; Huizinga TW; Toes RE; Trouw LA
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17372-7. PubMed ID: 21987802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.
    Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J
    J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affinity Purification and Comparative Biosensor Analysis of Citrulline-Peptide-Specific Antibodies in Rheumatoid Arthritis.
    Szarka E; Aradi P; Huber K; Pozsgay J; Végh L; Magyar A; Gyulai G; Nagy G; Rojkovich B; Kiss É; Hudecz F; Sármay G
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a Novel Serological Marker in Seronegative Rheumatoid Arthritis Using the Peptide Library Approach.
    Bason C; Barbieri A; Martinelli N; Olivieri B; Argentino G; Bartoloni E; Beri R; Jadav G; Puccetti A; Tinazzi E; Lunardi C
    Front Immunol; 2021; 12():753400. PubMed ID: 34675934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.
    Wu CY; Yang HY; Luo SF; Lai JH
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
    Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
    Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
    Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA
    Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis.
    van de Stadt LA; de Koning MH; van de Stadt RJ; Wolbink G; Dijkmans BA; Hamann D; van Schaardenburg D
    Arthritis Rheum; 2011 Nov; 63(11):3226-33. PubMed ID: 21792832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.